Clinical Trial

Fear of Falling in Muscular Dystrophy

Recruiting
View on ClinicalTrials.gov →
Summary
Primary objectives WP1: Evaluate the prevalence of FOF in the study population and how this varies over time. Evaluate whether there are relationships between the variables investigated (clinical, motor, cognitive, psychological) and the presence of FOF. WP2: To evaluate, among those who presented disabling FOF, the effects of two different therapeutic approaches: motor rehabilitation vs. motor rehabilitation plus cognitive-behavioral psychotherapy. Secondary objectives WP1: To evaluate whether different profiles defined by specific clinical, motor, cognitive, psychological, and personological characteristics can be characterized among patients with dystrophy and FOF and how these impact functionality, activity, participation, and quality of life. WP2: Evaluate the effects of cognitive-behavioral therapy (CBT) and a motor treatment on cognitive and psychological aspects, the frequency of falls, and the functional validity.
Trial Details
NCT Number NCT07129954
Lead Sponsor Universita di Verona
Conditions Fear of Falling, Duchenne Muscular Dystrophy (DMD), Muscular Dystrophies, Rehabilitation
Enrollment 100 participants
Start Date 2025-07-02
Primary Completion 2027-08-01 (estimated)
Study Completion 2027-08-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-19